◆英語タイトル：Herantis Pharma Plc (HRTIS) - Financial and Strategic SWOT Analysis Review
Herantis Pharma Plc (Herantis Pharma) is a drug development company that offers regenerative medicine for neurodegenerative diseases. The company’s pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease and lymfactin for secondary lymphedema. Its lymfactin recovers the damaged lymph system by reconstituting lymphatic vasculature. Herantis Pharma offers CDNF for disease modification in neurodegenerative diseases such as Parkinson’s and ALS. The company develops drug candidates through late pre-clinical and early clinical stages. It partners with pharmaceutical and biotech companies. Herantis Pharma is headquartered in Espoo, Finland.
Herantis Pharma Plc Key Recent Developments
Feb 28,2019: Herantis Pharma financial statements release January 1 – December 31, 2018
Feb 15,2019: Notice to convene Herantis Pharma Plc”s Extraordinary General Meeting of shareholders Notice to convene Herantis Pharma Plc”s Extraordinary General Meeting of shareholders Herantis Pharma Plc Company release 15 February 2019 at… Read More
Aug 29,2018: Herantis Pharma’s half year financial report January 1 – June 30, 2018
Jul 09,2018: Herantis Pharma to develop non-invasive CDNF for Parkinson’s
This comprehensive SWOT profile of Herantis Pharma Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Herantis Pharma Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Herantis Pharma Plc – Key Information
Herantis Pharma Plc – Overview
Herantis Pharma Plc – Key Employees
Herantis Pharma Plc – Key Employee Biographies
Herantis Pharma Plc – Key Operational Heads
Herantis Pharma Plc – Major Products and Services
Herantis Pharma Plc – History
Herantis Pharma Plc – Company Statement
Herantis Pharma Plc – Locations And Subsidiaries
Herantis Pharma Plc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Herantis Pharma Plc – Business Description
Herantis Pharma Plc – Corporate Strategy
Herantis Pharma Plc – SWOT Analysis
SWOT Analysis – Overview
Herantis Pharma Plc – Strengths
Herantis Pharma Plc – Weaknesses
Herantis Pharma Plc – Opportunities
Herantis Pharma Plc – Threats
Herantis Pharma Plc – Key Competitors
Section 3 – Company Financial Performance Charts
Herantis Pharma Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Herantis Pharma Plc, Key Information
Herantis Pharma Plc, Key Ratios
Herantis Pharma Plc, Share Data
Herantis Pharma Plc, Major Products and Services
Herantis Pharma Plc, History
Herantis Pharma Plc, Key Employees
Herantis Pharma Plc, Key Employee Biographies
Herantis Pharma Plc, Key Operational Heads
Herantis Pharma Plc, Other Locations
Herantis Pharma Plc, Subsidiaries
Herantis Pharma Plc, Key Manufacturing facilities
Herantis Pharma Plc, Key Competitors
Herantis Pharma Plc, SWOT Analysis
Herantis Pharma Plc, Ratios based on current share price
Herantis Pharma Plc, Annual Ratios
Herantis Pharma Plc, Interim Ratios
Capital Market Ratios
List of Figures
Herantis Pharma Plc, Performance Chart
Herantis Pharma Plc, Ratio Charts
| ★海外企業調査レポート[Herantis Pharma Plc (HRTIS)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら